Enhance exam efficiency with improved ergonomics and high-speed processing
FibroScan® Expert 630 is a point-of-care solution for high-volume hospital-based settings.
Complete Solution
Spleen Stiffness Measurement
All Patient Morphologies
Renowned & Endorsement
Unique capabilities of SSM by VCTE®
Assess and Monitor Portal Hypertension*
SSM by VCTE® helps to assess and monitor portal hypertension, the main driver of cirrhosis, in a quick and non-invasive way.
Helps to Assess the Presence of Esophageal Varices*
SSM by VCTE® can provide added value to help identify high-risk varices and prioritize endoscopies.
Determine Surgery*
SSM by VCTE® has the potential to triage patients in the general surgical population by assessing portal hypertension, a known risk factor, prior to surgery.
Physician & Operator Perspective
What our users say about Spleen Stiffness Measurement
Extend FibroScan® use
Beyond FibroScan®, Echosens offers complementary solutions designed to extend liver disease assessment, support clinical decision-making and optimize patient follow-up across different care pathways.
-
FibroScan® Gateway
Optimize clinical workflows with real-time secure data transmission
-
Guided VCTE®
Seamless liver health assessment for all
-
VCTE® probe
Optimize measurement accuracy on all patients of varying size
-
Liver Health Management
Cloud-based solution to assist clinicians in providing comprehensive liver care.
User testimonial
Read all testimonials
*SSM is a marker for non-invasive evaluation of spleen stiffness which has been used in a clinical setting to assess portal hypertension and for variceal surveillance.
1.Stefanescu H, et al. A novel spleen-dedicated stiffness measurement by FibroScan improves the screening of high-risk oesophageal varices. Liver Int. 2020;40(1):175-185. doi:10.1111/liv.14228.
2. Dajti, Elton et al. “A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.” The American journal of gastroenterology vol. 117,11 (2022): 1825-1833. doi:10.14309/ajg.0000000000001887.
3. Baveno VII – R. de Franchis et al. Renewing consensus in portal hypertension. Journal of hepatology vol. 76,4 (2022): 959-974. doi:10.1016/j.jhep.2021.12.022.
The FibroScan® Expert 630 is intended to measure liver stiffness (E) using Vibration Controlled Transient Elastography (VCTE®) at 50 Hz shear wave frequency and liver ultrasound attenuation coefficient (CAP)* at 3.5 MHz. FibroScan® 630 Expert is also intended to measure spleen stiffness using VCTE® at 100 Hz shear wave frequency. FibroScan liver stiffness measurements (LSM) by VCTE® may aid the physician in determining the likelihood of cirrhosis and may be used, taken in context with other clinical and laboratory data, as an aid in the assessment of liver fibrosis. FibroScan CAP measurements may be used, taken in context with other clinical and laboratory data, as an aid in the assessment of hepatic steatosis. FibroScan® is indicated as a non-invasive aid to clinical management, diagnosis, and monitoring of adult and pediatric patients with confirmed or suspected liver disease, as part of an overall assessment of the liver. Results in the pediatric population should be interpreted while considering the clinical condition and the overall patient profile. The FibroScan® device is intended for use by healthcare professionals in hospitals, clinics or any facility where healthcare is provided.
*CAP refers to ultrasound attenuation coefficient (originally defined as Controlled Attenuation Parameter). CAP on S+ probe is only available with SmartExam capability.